The Peter Mac study, published in PNAS and relying on Drosophila CNS models, demonstrates that the transcription factor Chinmo confers region-specific oncogenic competence, allowing identical mutations to drive tumors only where this protein is expressed. This is not an RCT but a controlled observational genetic screen in an invertebrate model organism with modest sample sizes typical of fly labs; no conflicts of interest are disclosed. Mainstream outlets fixate on downstream clinical trials, yet this work reveals a mechanistic gap: developmental timing and steroid-hormone regulation of Chinmo create permissive microenvironments that human glioblastoma research has largely ignored in favor of mutation catalogs. Cross-referencing with earlier Drosophila cancer modeling papers (e.g., Read et al., 2009, on EGFR/Ras cooperation) and human single-cell atlases of neural progenitors shows conserved competence windows that could explain why certain pediatric gliomas arise in specific brain territories. Targeting these transient states, rather than mutations alone, offers a preventive strategy mainstream coverage consistently misses.